MINNEAPOLIS - Bio-Techne Corporation (NASDAQ:TECH) announced today the launch of SPYRE Focus Panels and SPYRE Amplification Kits as additions to its COMET spatial biology solution portfolio, according ...

Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...

Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne's Analytical Solutions ...

In the latest quarter, 7 analysts provided ratings for Bio-Techne (NASDAQ:TECH), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the ...

For the quarter ended December 2025, Techne (TECH) reported revenue of $295.88 million, down 0.4% over the same period last year. EPS came in at $0.46, compared to $0.42 in the year-ago quarter. The ...

Feb 4 (Reuters) - Biotech firm Bio-Techne (TECH.O), opens new tab beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug ...

Bio-Techne Corp (TECH) reported its second-quarter results for fiscal year 2026, surpassing both earnings per share (EPS) and revenue forecasts. The company posted an EPS of $0.46, exceeding the ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Techne Corp. (TECH) on Wednesday reported fiscal second-quarter earnings of $38 million. On a per-share basis, the Minneapolis-based company said it had net ...

MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31 ...